ADVFN ADVFN

Hot Features

Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
PolyPid Ltd

PolyPid Ltd (PYPD)

5.02
-0.03
(-0.59%)
終了 7月5日 5:00AM
5.00
-0.02
(-0.40%)
取引時間後: 8:59AM

PolyPid Ltd (PYPD) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

主要統計と詳細

通貨
5.02
( -0.59% )
買値
4.80
売値
5.27
出来高
223,857
4.95 日の範囲 5.16
3.06 52 週間の範囲 5.24
時価総額
前日終値
5.05
始値
5.15
時刻
1
@
5.2
最終取引時間
財務取引量
US$ 1,132,472
VWAP
5.0589
平均取引量 (3 か月)
US$ 114,782
発行済株式数
19,174,078
配当利回り
PER
-2.84
1 株当たり利益 (EPS)
-1.78
歳入
-
純利益
-33.63M

PolyPid Ltd について

PolyPid Ltd., a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 c... PolyPid Ltd., a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. The company is also developing OncoPLEX, which is in preclinical stage for the treatment of intra-tumoral cancer. The company has a research and development collaboration with ImmunoGenesis, Inc. for the development of formulations to treat solid tumors. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Petah Tikva, Israel
設立
2026
PolyPid Ltd is listed in the Healthcare sector of the ナスダック市場 with ticker PYPD. The last closing price for PolyPid was US$5.05. Over the last year, PolyPid shares have traded in a share price range of US$ 3.06 to US$ 5.24.

PolyPid currently has 19,174,078 shares in issue. The market capitalisation of PolyPid is US$96.25 million. PolyPid has a price to earnings ratio (PE ratio) of -2.84.

PYPD 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.224.583333333334.85.244.532341214.93650998CS
40.36.355932203394.725.244.41588744.85802215CS
120.818.95734597164.225.244.181185434.77920873CS
260.6314.35079726654.395.244.0201871474.65480931CS
521.5444.25287356323.485.243.06838514.15692509CS
1564.641221.052631580.389.20.2006807923.33307052CS
260-3.8998-43.72071122678.91989.640.20061312252.34306426CS

PYPD - Frequently Asked Questions (FAQ)

What is the current PolyPid Ltd share price?
The current share price of PolyPid Ltd is US$ 5.02
How many PolyPid Ltd shares are in issue?
PolyPid Ltd has 19,174,078 shares in issue
What is the market cap of PolyPid Ltd?
The market capitalisation of PolyPid Ltd is USD 96.25M
What is the 1 year trading range for PolyPid Ltd share price?
PolyPid Ltd has traded in the range of US$ 3.06 to US$ 5.24 during the past year
What is the PE ratio of PolyPid Ltd?
The price to earnings ratio of PolyPid Ltd is -2.84
What is the registered address of PolyPid Ltd?
The registered address for PolyPid Ltd is 18 Hasivim Street, Petah Tikva, 4959376
What is the PolyPid Ltd website address?
The website address for PolyPid Ltd is www.polypid.com
Which industry sector does PolyPid Ltd operate in?
PolyPid Ltd operates in the Biotechnology & Life Sciences sector

PYPD 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock